CLINICAL_TRIALS
trial_result
· 2014-01-16
Clinical Trial Update: Safety Study: Combined Modality Treatment for Non-Small Cell Lung Cancer [Phase 1]
Summary
Phase 1 safety trial of a combined modality treatment for non-small cell lung cancer was terminated.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Atlantic Health System | Conditions: Non-Small Cell Lung Cancer | Phase 1 | Status: TERMINATED